stars 1 stars 2 stars 3

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.

View Top Employees from Dunad Therapeutics
Website https://www.dunadtx.com
Employees 35 (27 on RocketReach)
Founded 2020
Industry Biotechnology Research

Dunad Therapeutics Questions

Holly Whittemore is the Chief Operating Officer and Treasurer of Dunad Therapeutics.

27 people are employed at Dunad Therapeutics.

Top Dunad Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users